A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell ...

State data from 2018 through 2022 shows prostate cancer is the leading cancer diagnosis in Cuyahoga County, yet 77% of cases ...

No significant improvement seen in overall survival with addition of hormone therapy to post-radical prostatectomy radiotherapy.

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...

A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University Hospitals Seidman ...

A leading hospital in Kenya has launched an artificial intelligence-powered radiotherapy system, expanding advanced cancer ...

After a significant ruling from the Supreme Court of Appeal, prostate cancer patients in South Africa can continue to access ...

Aga Khan University Hospital bets in Kenya has launched an artificial intelligence-powered radiotherapy system, expanding ...

By Tim BakerClose readers of this blog and, indeed, the PCFA website, may have picked up on the carefully guarded secret that ...

Cardiovascular disease is the second leading cause of death among cancer survivors, second only to cancer itself. The same treatments that can save patients from cancer may also r ...

A former Rosyth dockyard worker has revealed the 'horrendous' experience of his prostate cancer to encourage men to get tested. Alex Keatings, 68, who worked for decades as a manager for the aircraft ...